Prognostic significance of preoperative mean platelet volume in resected non-small‑cell lung cancer

Kumagai,Shogo; Tokuno,Junko; Ueda,Yuichiro; Marumo,Satoshi; Shoji,Tsuyoshi; Nishimura,Takafumi; Fukui,Motonari; Huang,Cheng-Long

doi:10.3892/mco.2014.436

January-February 2015 Volume 3 Issue 1

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

January-February 2015 Volume 3 Issue 1

Full Size Image

Article

Prognostic significance of preoperative mean platelet volume in resected non-small‑cell lung cancer

Authors:
- Shogo Kumagai
- Junko Tokuno
- Yuichiro Ueda
- Satoshi Marumo
- Tsuyoshi Shoji
- Takafumi Nishimura
- Motonari Fukui
- Cheng-Long Huang
View Affiliations

Affiliations: Respiratory Disease Center, Tazuke Kofukai Medical Research Institute, Kitano Hospital, Osaka 530-8480, Japan, Department of Medical Oncology, Tazuke Kofukai Medical Research Institute, Kitano Hospital, Osaka 530-8480, Japan
Published online on: October 6, 2014 https://doi.org/10.3892/mco.2014.436
Pages: 197-201

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

An increased mean platelet volume (MPV) is an early marker of platelet activation. MPV was also shown to be associated with the pathophysiological characteristics of various types of cancer. A previous study demonstrated that MPV was significantly associated with the overall survival (OS) of patients with advanced non-small‑cell lung cancer (NSCLC). However, there has been no analysis of the prognostic effect of MPV on patients with resected NSCLC. The aim of this study was to evaluate the contribution of MPV to the survival of patients with completely resected NSCLC. We retrospectively analyzed 308 consecutive patients with NSCLC who underwent curative resection at Kitano Hospital. The associations between MPV and clinicopathological factors were assessed. We also evaluated the effect of MPV on survival, using the two‑tailed log-rank test and the Cox proportional hazards model. a MPV value of 8.50 fl was considered to be the optimal cut-off value for prognosis. A low MPV was not associated with any other clinicopathological factors. The two-tailed log-rank test demonstrated that patients with a low MPV experienced a shorter disease-free survival (DFS) and overall survival (OS) (P=0.011 and 0.001, respectively), compared to those with a high MPV. The multivariate analysis demonstrated that a low MPV was an independent unfavorable prognostic factor for DFS and OS [hazard ratio (HR)=1.713; 95% confidence interval (CI): 1.070‑2.742, P=0.025; and HR=2.835; 95% CI: 1.304‑6.163, P=0.009, respectively)]. Therefore, we demonstrated that a low MPV predicted an unfavorable prognosis in patients with NSCLC following curative resection.

View Figures

View References

1	Thompson CB and Jakubowski JA: The pathophysiology and clinical relevance of platelet heterogeneity. Blood. 72:1–8. 1988.PubMed/NCBI
2	Thompson CB, Jakubowski JA, Quinn PG, et al: Platelet size and age determine platelet function independently. Blood. 63:1372–1375. 1984.PubMed/NCBI
3	Martin JF, Bath PM and Burr ML: Influence of platelet size on outcome after myocardial infarction. Lancet. 338:1409–1411. 1991. View Article : Google Scholar : PubMed/NCBI
4	Tohgi H, Suzuki H, Tamura K, et al: Platelet volume, aggregation, and adenosine triphosphate release in cerebral thrombosis. Stroke. 22:17–21. 1991.PubMed/NCBI
5	Aoe K, Hiraki A, Ueoka H, et al: Thrombocytosis as a useful prognostic indicator in patients with lung cancer. Respiration. 71:170–173. 2004. View Article : Google Scholar : PubMed/NCBI
6	Maráz A, Furák J, Varga Z, et al: Thrombocytosis has a negative prognostic value in lung cancer. Anticancer Res. 33:1725–1730. 2013.PubMed/NCBI
7	Inagaki N, Kibata K, Tamaki T, et al: Prognostic impact of the mean platelet volume/platelet count ratio in terms of survival in advanced non-small cell lung cancer. Lung Cancer. 83:97–101. 2014.
8	World Health Organization, . Tumours of the lungTumours of the Lung, Pleura, Thymus and Heart. Travis WD, Bramvilla E, Muller-Hermelink HK and Harris CC: International Agency for Research on Cancer; Lyon: pp. 102004
9	Sobin LH, Gospodarowicz MK and Wittekind C: International Union Against Cancer (UICC): TNM classification of malignant tumours. 7th. John Willkey and Sons, Ltd.; UK: 2010
10	Kaplan E and Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:457–481. 1958. View Article : Google Scholar
11	Thompson CB, Eaton KA, Princiotta SM, et al: Size dependent platelet subpopulations: relationship of platelet volume to ultrastructure, enzymatic activity, and function. Br J Haematol. 50:509–519. 1982.PubMed/NCBI
12	Jakubowski JA, Thompson CB, Vaillancourt R, et al: Arachidonic acid metabolism by platelets of differing size. Br J Haematol. 53:503–511. 1983. View Article : Google Scholar : PubMed/NCBI
13	Giles H, Smith RE and Martin JF: Platelet glycoprotein IIb-IIIa and size are increased in acute myocardial infarction. Eur J Clin Invest. 24:69–72. 1994. View Article : Google Scholar : PubMed/NCBI
14	Aksoy S, Kilickap S, Hayran M, et al: Platelet size has diagnostic predictive value for bone marrow metastasis in patients with solid tumors. Int J Lab Hematol. 30:214–219. 2008. View Article : Google Scholar : PubMed/NCBI
15	Thomas GM, Panicot-Dubois L, Lacroix R, et al: Cancer cell-derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo. J Exp Med. 206:1913–1927. 2009. View Article : Google Scholar : PubMed/NCBI
16	Falanga A, Panova-Noeva M and Russo L: Procoagulant mechanisms in tumour cells. Best Pract Res Clin Haematol. 22:49–60. 2009. View Article : Google Scholar : PubMed/NCBI
17	Mutlu H, Artis TA, Erden A and Akca Z: Alteration in mean platelet volume and platicrit values in patients with cancer that developed thrombosis. Clin Appl Thromb Hemost. 19:331–333. 2013.PubMed/NCBI
18	Nash GF, Turner LF, Scully MF, et al: Platelets and cancer. Lancet Oncol. 3:425–430. 2002. View Article : Google Scholar
19	Zhang W, Dang S, Hong T, et al: A humanized single-chain antibody against beta 3 integrin inhibits pulmonary metastasis by preferentially fragmenting activated platelets in the tumor microenvironment. Blood. 120:2889–2898. 2012. View Article : Google Scholar
20	Riedl J, Kaider A, Reitter EM, et al: Association of mean platelet volume with risk of venous thromboembolism and mortality in patients with cancer. Results from the Vienna Cancer and Thrombosis Study (CATS). Thromb Haemost. 111:670–678. 2014.PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Prognostic significance of preoperative mean platelet volume in resected non-small‑cell lung cancer

This article is mentioned in:

Abstract

Figure 1

Figure 2

Related Articles